Historically, we immunized children against diseases like polio that were a clear danger to them, but COVID-19 is usually mild in children. However, herd immunity is unlikely without vaccinating kids.
L’expertise universitaire, l’exigence journalistique
Articles sur COVID-19 vaccine
Affichage de 1 à 20 de 77 articles
As COVID-19 vaccines roll out, a debate about whether athletes should be prioritized over more vulnerable populations has emerged.
We have limited information about the reported deaths of 30 elderly people in Norway who had received the Pfizer COVID vaccine. Here's what we do know.
In the early years of the United States, several American presidents were in favour of public health inoculation and vaccination strategies.
Massive vaccine distribution efforts take a lot of coordination. The rollout of the Salk polio vaccine in the US in 1955 holds lessons for those delivering COVID-19 shots today.
Two in five Americans say they don't want a COVID-19 vaccine, which is a problem. Finding out what Americans do want from a vaccine might help.
Australia's expedited plan to start dishing out COVID jabs in mid-late February will call for NASA-like logistical organisation. And ideally, no more clusters of infections to distract frontline workers.
Even though the idea has been rejected earlier in the COVID-19 pandemic, we need to rethink immunity passports. Here's why.
A serious allergic reaction was reported in a health care worker in Alaska after she received the COVID-19 vaccine. Does this mean that people with allergies need to be concerned? An expert answers.
We still don't know if current vaccines prevent people from transmitting the virus to others. Here's why that matters in 2021.
When allocating resources, we prioritize members of the social groups we belong to, rather than including others in our allocations. This will determine how the COVID-19 vaccine is distributed.
We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
Millions of Americans say they won't get the vaccine. Will money change their minds? And is luring them with cash the right approach?
If the vaccine had been widely rolled out, people would think they had HIV when they didn't. But it's not the end of this type of technology.
Reports of two UK health workers having allergic reactions after receiving Pfizer's COVID vaccine have led to safety warnings for others at risk of anaphylaxis.
Compared with other RNA viruses, the coronavirus is actually quite stable. So don't believe the scary headlines about the 'mutant coronavirus'.
Millions of Latinos may not get the influenza shot this year, which could be an indicator of whether they will get a COVID-19 shot. A rural clinic shows how building trust can help overcome reluctance.
If supplies of COVID-19 vaccine are initially limited, who should be vaccinated first? A mathematical model shows when and why it’s best to start with the young, and when older people should go first.
Here’s what you need to know about COVID-19 clearances before travelling.
A 1904 revolt against mandatory smallpox inoculation taught Brazilian health officials a deadly lesson on how to vaccinate a skeptical public. Today President Bolsonaro seems to ignore that history.
Les contributeurs les plus fréquents
-
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Associate professor, UNSW
-
Assistant Professor of Law, Saint Louis University
-
Senior Lecturer in Law, University of Western Australia
-
Assistant Professor of Political Science, Oklahoma State University
-
Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University
-
Professor of medicine, epidemiology & biostatistics, and philosophy, Western University
-
Professor of Immunology, RMIT University
-
Professor of Immunology and Associate Dean, Research and Graduate Studies, University of Guelph
-
Infectious Diseases Specialist and Clinical Professor, University of Tasmania
-
Associate Professor of Viral Immunology, Department of Pathobiology, University of Guelph
-
Professor Emerita; Immediate Past President, APHA, Purdue University
